Table 1.
Variable | χ ± SD or cases (%) | Range |
---|---|---|
Age (years) | 32.05 ± 8.38 | 20–58 |
Gender (male, %) | 61 (100%) | |
Infection duration (months) | 11.16 ± 1.19 | 1–86 |
T lymphocyte subsets | ||
CD3+ count (cells/µL) | 1433.98 ± 595.35 | 470–3074 |
CD3+CD4+ count (cells/µL) | 313.87 ± 118.473 | 54–499 |
CD3+CD4+ percentage (%) | 19.78 ± 6.83 | 1.40–43.40 |
CD3+CD8+ count (cells/µL) | 1119.70 ± 605.0 | 360–2456 |
CD3+CD8+ percentage (%) | 69.97 ± 13.80 | 36.13–97.20 |
Virus load of HIVRNAa | 41772.77 ± 10.38 | 895.00–505987.00 |
Metabolic parameters | ||
TG (mmol/L) | 1.68 ± 1.23 | 0.39–16.81 |
TC (mmol/L) | 4.20 ± 0.72 | 2.38–6.09 |
LDL-c (mmol/L) | 2.61 ± 0.68 | 0.92–4.71 |
HDL-c (mmol/L) | 1.12 ± 0.24 | 0.57–1.77 |
UA (µmol/L) | 310.72 ± 68.65 | 143–506 |
Anthropometric parameters | ||
Body weight (kg) | 62.41 ± 10.53 | 46–85 |
Body mass index (kg/m2) | 21.38 ± 2.82 | 16.80–28.20 |
Body fat percentage (%) | 15.99 ± 6.32 | 3–28.4 |
Body fat weight (kg) | 10.40 ± 5.33 | 1.4–22.10 |
Body nonfat weight (kg) | 51.82 ± 6.67 | 35.8–64.7 |
Baseline body mass status | ||
Body mass index<18 kg/m2 | 3 (4.92) | |
24 kg/m2 ≥ Body mass index ≥ 18 kg/m2 | 49 (80.33) | |
Body mass index > 24 kg/m2 | 9 (14.75) |
TG, triglyceride; TC, total cholesterol; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol; UA, uric acid
aLogarithmic transformation before statistical analysis for nonnormally distributed data